Literature DB >> 21174588

Placental microparticles, DNA, and RNA in preeclampsia.

Corinne Rusterholz1, Marianne Messerli, Irene Hoesli, Sinuhe Hahn.   

Abstract

Preeclampsia is a common disorder of the second half of pregnancy that complicates 2% to 7% of all pregnancies worldwide and remains a major cause of maternal and fetal morbidity and mortality. Although the origin of the disease is still elusive, population-based studies have suggested that it might implicate genetic, immunologic, or physiologic factors. On the other hand, there is no doubt that the placenta plays an important role in its development. In preeclampsia, the shedding of placenta debris, such as syncytiotrophoblast microparticles (STBMs) and DNA and messenger RNA molecules, into the maternal peripheral blood is increased. The analysis of this material may give new insight into placentation and the underlying etiology of this disorder, as well as yield new tracks of research for the understanding of the molecular mechanisms, leading to the generation of the clinical symptoms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21174588     DOI: 10.3109/10641951003599571

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  9 in total

1.  Cellular fetal microchimerism in preeclampsia.

Authors:  Hilary S Gammill; Tessa M Aydelotte; Katherine A Guthrie; Evangelyn C Nkwopara; J Lee Nelson
Journal:  Hypertension       Date:  2013-10-07       Impact factor: 10.190

Review 2.  Galectins: Double-edged Swords in the Cross-roads of Pregnancy Complications and Female Reproductive Tract Inflammation and Neoplasia.

Authors:  Nandor Gabor Than; Roberto Romero; Andrea Balogh; Eva Karpati; Salvatore Andrea Mastrolia; Orna Staretz-Chacham; Sinuhe Hahn; Offer Erez; Zoltan Papp; Chong Jai Kim
Journal:  J Pathol Transl Med       Date:  2015-05-15

3.  Stimulation of monocytes by placental microparticles involves toll-like receptors and nuclear factor kappa-light-chain-enhancer of activated B cells.

Authors:  Marianne Simone Joerger-Messerli; Irene Mathilde Hoesli; Corinne Rusterholz; Olav Lapaire
Journal:  Front Immunol       Date:  2014-04-15       Impact factor: 7.561

Review 4.  A Dormant Microbial Component in the Development of Preeclampsia.

Authors:  Douglas B Kell; Louise C Kenny
Journal:  Front Med (Lausanne)       Date:  2016-11-29

5.  Immunological Tolerance, Pregnancy, and Preeclampsia: The Roles of Semen Microbes and the Father.

Authors:  Louise C Kenny; Douglas B Kell
Journal:  Front Med (Lausanne)       Date:  2018-01-04

6.  Placenta-derived extracellular vesicles induce preeclampsia in mouse models.

Authors:  Cha Han; Chenyu Wang; Yuanyuan Chen; Jiwei Wang; Xin Xu; Tristan Hilton; Wei Cai; Zilong Zhao; Yingang Wu; Ke Li; Katie Houck; Li Liu; Anil K Sood; Xiaoping Wu; Fengxia Xue; Min Li; Jing-Fei Dong; Jianning Zhang
Journal:  Haematologica       Date:  2019-08-22       Impact factor: 9.941

Review 7.  Syncytiotrophoblast-Derived Extracellular Vesicles in Pathophysiology of Preeclampsia.

Authors:  Cha Han; Lulu Han; Pengzhu Huang; Yuanyuan Chen; Yingmei Wang; Fengxia Xue
Journal:  Front Physiol       Date:  2019-10-01       Impact factor: 4.566

8.  Non-invasive Prenatal Testing: Technologies, Clinical Assays and Implementation Strategies for Women's Healthcare Practitioners.

Authors:  Amy Swanson; Amy J Sehnert; Sucheta Bhatt
Journal:  Curr Genet Med Rep       Date:  2013-03-17

9.  Excessive Neutrophil Activity in Gestational Diabetes Mellitus: Could It Contribute to the Development of Preeclampsia?

Authors:  Lenka Vokalova; Shane V van Breda; Xi Lun Ye; Evelyn A Huhn; Nandor G Than; Paul Hasler; Olav Lapaire; Irene Hoesli; Simona W Rossi; Sinuhe Hahn
Journal:  Front Endocrinol (Lausanne)       Date:  2018-09-21       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.